Detailed information about the 100 most recent patent applications.
| Application Number | Title | Filing Date | Disposal Date | Disposition | Time (months) | Office Actions | Restrictions | Interview | Appeal |
|---|---|---|---|---|---|---|---|---|---|
| 19207572 | FLUID MEASURING RESERVOIR FOR BREAST PUMPS | May 2025 | August 2025 | Allow | 3 | 1 | 0 | Yes | No |
| 19031780 | DOSAGE MANAGEMENT AND PATIENT EDUCATION USING AN INTELLIGENT INJECTION DEVICE | January 2025 | December 2025 | Allow | 11 | 1 | 1 | Yes | No |
| 18752035 | Gravity-Fed Burette System | June 2024 | April 2025 | Allow | 10 | 1 | 0 | Yes | No |
| 18638167 | EPISTAXIS CONTROLLING DEVICE AND METHOD OF USING THE SAME | April 2024 | February 2025 | Allow | 10 | 1 | 1 | No | No |
| 18607862 | ASPIRATION MEDICAL DEVICE | March 2024 | July 2025 | Allow | 16 | 1 | 0 | No | No |
| 18605302 | Autoinjector | March 2024 | November 2025 | Allow | 20 | 1 | 0 | No | No |
| 18601899 | Intravenous Catheter Insertion Device and Method of Use | March 2024 | March 2025 | Allow | 12 | 1 | 0 | No | No |
| 18581629 | Flush Syringe With Flip Cap | February 2024 | January 2025 | Allow | 11 | 1 | 0 | No | No |
| 18433332 | INJECTION DEVICES AND METHODS FOR MAKING AND USING THEM | February 2024 | March 2026 | Allow | 25 | 1 | 0 | No | No |
| 18394510 | TREATMENT OF NEUROMUSCULAR DYSFUNCTION | December 2023 | June 2024 | Allow | 5 | 1 | 0 | Yes | No |
| 18543869 | Substance Delivery Apparatus | December 2023 | June 2025 | Abandon | 18 | 1 | 0 | No | No |
| 18542545 | FORMULATIONS AND METHODS FOR DIRECT SODIUM REMOVAL IN PATIENTS HAVING HEART FAILURE AND/OR SEVERE RENAL DYSFUNCTION | December 2023 | August 2025 | Allow | 20 | 2 | 0 | No | No |
| 18524681 | INSERTER | November 2023 | September 2025 | Allow | 22 | 2 | 0 | No | No |
| 18524986 | Injection Device | November 2023 | July 2025 | Allow | 19 | 2 | 0 | Yes | No |
| 18515771 | SYSTEM AND METHOD FOR ULTRASOUND-ENHANCED DELIVERY OF DRUGS | November 2023 | December 2025 | Allow | 24 | 3 | 0 | Yes | No |
| 18514784 | AUTO INJECTOR WITH RECONSTITUTION HANDLING SUPPORT | November 2023 | September 2025 | Allow | 22 | 1 | 0 | No | No |
| 18500055 | DEVICE FOR DELIVERING AN ANTIMICROBIAL COMPOSITION INTO A MEDICAL DEVICE | November 2023 | May 2025 | Allow | 19 | 1 | 0 | Yes | No |
| 18484101 | STABILIZATION DEVICES FOR USE WITH LOW-PROFILE FEEDING DEVICES AND RELATED METHODS OF USING THE SAME | October 2023 | May 2025 | Abandon | 19 | 1 | 0 | No | No |
| 18473439 | ROBOTIC PERCUTANEOUS DEVICE WIPER | September 2023 | February 2025 | Allow | 17 | 1 | 0 | No | No |
| 18238796 | FLOW METER HAVING A VALVE | August 2023 | October 2025 | Allow | 26 | 2 | 0 | No | No |
| 18348855 | MEDICAL CONNECTOR | July 2023 | November 2025 | Allow | 28 | 1 | 0 | No | No |
| 18218884 | Autoinjector | July 2023 | February 2024 | Allow | 7 | 1 | 0 | Yes | No |
| 18215934 | Methods and Devices for Paranasal Sinus Drug Delivery | June 2023 | October 2025 | Allow | 28 | 2 | 0 | Yes | No |
| 18211799 | SUCTION AND IRRIGATION DEVICE | June 2023 | April 2025 | Allow | 21 | 1 | 0 | Yes | No |
| 18195191 | DRUG DELIVERY SYSTEM WITH MULTIPOLAR MAGNET AND SENSOR SYSTEM | May 2023 | October 2025 | Allow | 29 | 2 | 0 | No | No |
| 18309919 | SENSOR DEVICE FOR ATTACHMENT TO AN INJECTION DEVICE | May 2023 | February 2026 | Allow | 33 | 3 | 0 | Yes | No |
| 18131502 | INJECTION DEVICE | April 2023 | April 2025 | Allow | 25 | 1 | 0 | No | No |
| 18115131 | PHARMACEUTICAL CONTAINER AND LIQUID COMPOSITION | February 2023 | September 2025 | Allow | 31 | 2 | 1 | No | No |
| 18112265 | FRONT LOADED AUTO INJECTOR FOR ADMINISTERING A MEDICAMENT | February 2023 | March 2025 | Allow | 25 | 1 | 0 | No | No |
| 18157741 | FORMULATIONS AND METHODS FOR DIRECT SODIUM REMOVAL IN PATIENTS HAVING HEART FAILURE AND/OR SEVERE RENAL DYSFUNCTION | January 2023 | August 2023 | Allow | 7 | 1 | 0 | No | No |
| 18016184 | SYSTEM AND METHOD FOR INFORMATION MANAGEMENT IN COMPUTERIZED INJECTORS | January 2023 | March 2026 | Allow | 38 | 1 | 0 | Yes | No |
| 18084167 | Medicament Delivery Device | December 2022 | June 2025 | Allow | 30 | 2 | 0 | No | No |
| 18061287 | INTRABODY SURGICAL FLUID TRANSFER ASSEMBLIES WITH ADJUSTABLE EXPOSED CANNULA TO NEEDLE TIP LENGTH, RELATED SYSTEMS AND METHODS | December 2022 | May 2025 | Allow | 29 | 1 | 1 | No | No |
| 18061385 | DEVICE FOR DELIVERING AN ANTIMICROBIAL COMPOSITION INTO A MEDICAL DEVICE | December 2022 | December 2025 | Allow | 36 | 3 | 0 | Yes | No |
| 17980094 | THERAPEUTIC APPLICATIONS OF ARTIFICIAL CEREBROSPINAL FLUID AND TOOLS PROVIDED THEREFOR | November 2022 | March 2025 | Abandon | 29 | 1 | 0 | No | No |
| 17974212 | DIGITAL MICROFLUIDIC DELIVERY DEVICE | October 2022 | October 2024 | Allow | 23 | 1 | 0 | No | No |
| 17969409 | DELIVERY DEVICE | October 2022 | September 2024 | Allow | 23 | 1 | 0 | No | No |
| 17918812 | INJECTION SYRINGE | October 2022 | January 2026 | Allow | 39 | 1 | 0 | No | No |
| 17962785 | DIRECT STREAM HYDRODYNAMIC CATHETER SYSTEM | October 2022 | June 2025 | Allow | 32 | 3 | 0 | Yes | No |
| 17938418 | IMPLANTABLE PUMP FOR DIRECT SODIUM REMOVAL THERAPY HAVING ON-BOARD ANALYTE SENSOR | October 2022 | January 2026 | Allow | 39 | 1 | 0 | No | No |
| 17938161 | Hazardous Agent Injection System | October 2022 | March 2025 | Allow | 29 | 2 | 0 | No | No |
| 17933427 | Electroporation Device and Injection Apparatus | September 2022 | February 2025 | Abandon | 29 | 1 | 0 | No | No |
| 17823388 | MEDICATION INFUSION COMPONENTS AND SYSTEMS | August 2022 | September 2024 | Allow | 25 | 1 | 0 | No | No |
| 17823393 | MEDICATION INFUSION COMPONENTS AND SYSTEMS | August 2022 | October 2025 | Abandon | 38 | 2 | 0 | Yes | No |
| 17798959 | AN INJECTION DEVICE WITH INTEGRATED NEEDLES | August 2022 | July 2025 | Abandon | 35 | 1 | 0 | No | No |
| 17760164 | PROTECTED STERILE INJECTOR WITH READY ISOTONIC | August 2022 | January 2026 | Abandon | 41 | 1 | 0 | No | No |
| 17876869 | RFID TAG ENABLED NEEDLE SHIELD | July 2022 | October 2025 | Allow | 38 | 1 | 0 | No | No |
| 17860514 | Method for Bubble-Free Gas-Enrichment of a Flowing Liquid within a Conduit | July 2022 | September 2024 | Allow | 26 | 1 | 0 | No | No |
| 17843908 | MEDICAL DEVICE WITH ANTIMICROBIAL PROPERTIES | June 2022 | September 2024 | Allow | 27 | 1 | 0 | No | No |
| 17837461 | Adaptor and Drug Delivery Device | June 2022 | July 2025 | Allow | 37 | 1 | 0 | No | No |
| 17835663 | DEVICE CONTAINER | June 2022 | October 2025 | Allow | 40 | 1 | 0 | No | No |
| 17831974 | ELECTRONICS FOR DOSAGE SENSING | June 2022 | December 2024 | Allow | 30 | 1 | 0 | Yes | No |
| 17826508 | Hub Component for Vented Connector | May 2022 | March 2025 | Allow | 33 | 2 | 0 | Yes | No |
| 17741314 | AUTO INJECTOR WITH TEMPERATURE CONTROL | May 2022 | February 2025 | Allow | 33 | 2 | 0 | No | No |
| 17661907 | MEDICAL DELIVERY DEVICE WITH LAMINATED STOPPER | May 2022 | May 2024 | Allow | 25 | 1 | 0 | No | No |
| 17661735 | MEDICAL DELIVERY DEVICE WITH LAMINATED STOPPER | May 2022 | May 2024 | Allow | 24 | 1 | 0 | No | No |
| 17726381 | Autoinjector | April 2022 | April 2024 | Allow | 24 | 0 | 0 | No | No |
| 17724177 | REPORTING SYRINGE | April 2022 | January 2026 | Allow | 45 | 4 | 0 | Yes | No |
| 17635146 | PEN-LIKE SYRINGE SYSTEM | February 2022 | November 2025 | Allow | 45 | 1 | 0 | Yes | No |
| 17670700 | CAP ASSEMBLY FOR A MEDICAMENT DELIVERY DEVICE | February 2022 | May 2024 | Allow | 27 | 1 | 0 | No | No |
| 17634680 | Medicament Container with Electronic Identifier | February 2022 | August 2025 | Abandon | 42 | 1 | 0 | No | No |
| 17592360 | INTERCHANGEABLE FLUSH/SELECTIVE CATHETER | February 2022 | June 2024 | Allow | 29 | 1 | 0 | No | No |
| 17646009 | TRANSDERMAL PATCH PROVIDING IMPROVED PERMEABILITY AND COMPOSITION | December 2021 | October 2024 | Allow | 33 | 3 | 1 | Yes | No |
| 17558839 | SYSTEMS, APPARATUSES AND METHODS TO ENCOURAGE INJECTION SITE ROTATION AND PREVENT LIPODYSTROPHY FROM REPEATED INJECTIONS TO A BODY AREA | December 2021 | February 2023 | Allow | 14 | 2 | 0 | Yes | No |
| 17556153 | METHOD AND APPARATUS FOR INJECTING A NEUROTOXIN INTO A LOCALIZED AREA | December 2021 | September 2024 | Abandon | 33 | 1 | 0 | No | No |
| 17536954 | INJECTION DEVICE WITH CAMMED RAM ASSEMBLY | November 2021 | August 2024 | Allow | 33 | 2 | 0 | No | No |
| 17531231 | Oral Product Delivery Device | November 2021 | November 2025 | Allow | 48 | 3 | 0 | Yes | No |
| 17529150 | AUTO INJECTOR WITH DETECTION OF USED CARTRIDGE AND ASSOCIATED METHOD | November 2021 | January 2024 | Allow | 26 | 1 | 0 | No | No |
| 17450887 | Supplementary Device for a Manually Operable Injection Device | October 2021 | May 2025 | Allow | 43 | 1 | 0 | No | No |
| 17500529 | Apparatus and System for Diabetes Management | October 2021 | August 2025 | Abandon | 46 | 1 | 0 | No | No |
| 17499612 | MEDICATION INFUSION COMPONENTS AND SYSTEMS | October 2021 | June 2024 | Allow | 32 | 2 | 0 | Yes | No |
| 17496536 | FEED-FORTIFY ENTERAL FEEDING AND RELATED METHODS THEREFOR | October 2021 | February 2024 | Allow | 28 | 1 | 0 | No | No |
| 17495962 | SYRINGE APPARATUS FOR DISINFECTION OF CENTRAL LINE PORT NEEDLELESS CONNECTOR AND METHOD OF DISINFECTING A CENTRAL LINE PORT NEEDLELESS CONNECTOR | October 2021 | April 2024 | Abandon | 30 | 1 | 0 | No | No |
| 17468558 | DRUG DELIVERY DEVICE | September 2021 | November 2023 | Allow | 27 | 1 | 0 | No | No |
| 17464749 | INFUSION DEVICE WITH STABILIZER MEMBER | September 2021 | May 2024 | Allow | 33 | 2 | 0 | No | No |
| 17400985 | SYSTEMS AND METHODS FOR POSITIONING FLUID SUPPLY SYSTEM | August 2021 | May 2025 | Abandon | 45 | 4 | 0 | No | No |
| 17386770 | Flush Syringe With Flip Cap | July 2021 | October 2023 | Allow | 27 | 2 | 0 | No | No |
| 17425513 | NEEDLELESS INJECTION DEVICE | July 2021 | October 2025 | Allow | 51 | 3 | 0 | No | No |
| 17362665 | NEEDLELESS INJECTORS AND RELATED METHODS | June 2021 | December 2024 | Allow | 42 | 1 | 0 | No | No |
| 17359825 | WEARABLE INJECTOR WITH STERILE ADHESIVE PATCH | June 2021 | August 2024 | Allow | 38 | 2 | 0 | Yes | No |
| 17244262 | MICRO-NEEDLE ARRAY UNIT | April 2021 | January 2025 | Abandon | 45 | 2 | 0 | No | No |
| 17243402 | SYRINGES AND MEDICAL DEVICES WITH WINDOWED LABELS | April 2021 | October 2023 | Allow | 29 | 3 | 0 | Yes | No |
| 17301855 | GUIDE CATHETER CONTROL FLEXIBLE TRACK | April 2021 | December 2023 | Allow | 32 | 2 | 0 | No | No |
| 17224975 | PROTECTIVE MEMBRANE FOR MEDICAL LUER CONNECTORS | April 2021 | March 2026 | Allow | 59 | 4 | 0 | No | No |
| 17283318 | INTEGRATED MULTI-MEDICATION TREATMENT DELIVERY SYSTEM | April 2021 | March 2025 | Abandon | 47 | 2 | 0 | Yes | No |
| 17281769 | DELIVERY DEVICE | March 2021 | June 2022 | Allow | 14 | 3 | 0 | No | No |
| 17218298 | SYRINGE APPARATUS FOR DISINFECTION OF CENTRAL LINE PORT NEEDLELESS CONNECTOR AND METHOD OF DISINFECTING A CENTRAL LINE PORT NEEDLELESS CONNECTOR | March 2021 | September 2021 | Allow | 5 | 1 | 0 | No | No |
| 17213777 | SYSTEMS, COMPONENTS, AND COMBINATIONS THEREOF FOR PEN-TYPE INJECTION DEVICES | March 2021 | February 2025 | Allow | 47 | 3 | 1 | No | No |
| 17214471 | IMPLANTS WITH CONTROLLED DRUG DELIVERY FEATURES AND METHODS OF USING SAME | March 2021 | January 2024 | Allow | 34 | 2 | 0 | Yes | No |
| 17213115 | Autoinjector | March 2021 | November 2025 | Allow | 56 | 2 | 0 | Yes | No |
| 17195825 | Medical Fluid Cassette Leak Detection Methods And Devices | March 2021 | June 2025 | Allow | 51 | 1 | 0 | No | No |
| 17193395 | PHARMACEUTICAL PACKAGING RECEPTACLE WITH A LUBRICANT LAYER FOR REMOVAL OF A CHARGE | March 2021 | December 2023 | Allow | 33 | 1 | 0 | No | No |
| 17187435 | SUCTION AND IRRIGATION DEVICE | February 2021 | April 2023 | Allow | 26 | 1 | 0 | No | No |
| 17182431 | STABILIZATION DEVICES FOR USE WITH LOW-PROFILE FEEDING DEVICES AND RELATED METHODS OF USING THE SAME | February 2021 | August 2023 | Allow | 30 | 2 | 0 | Yes | No |
| 17172211 | Sensor Assembly and System, Method, and Computer Program Product for Identifying Devices Connected to Device Connectors | February 2021 | February 2026 | Allow | 60 | 5 | 0 | No | No |
| 17173011 | CANNULATION TIME TRACKING | February 2021 | November 2023 | Allow | 33 | 2 | 0 | No | No |
| 17168862 | DETECTION AND COMMUNICATION OF PLUNGER POSITION USING INDUCTION | February 2021 | February 2023 | Allow | 25 | 1 | 0 | No | No |
| 17168784 | TUBULAR INSTRUMENT TO REDUCE VEIN TRAUMA AND RELATED DEVICES AND METHODS | February 2021 | February 2025 | Allow | 48 | 6 | 0 | Yes | No |
| 17167805 | MULTIPURPOSE CAPACITIVE SENSOR FOR FLUID PUMPS | February 2021 | February 2025 | Allow | 48 | 1 | 0 | No | No |
| 17265352 | OCCLUSION CATHETER SYSTEM FOR FULL OR PARTIAL OCCLUSION | February 2021 | April 2024 | Allow | 38 | 2 | 0 | Yes | No |
This analysis examines appeal outcomes and the strategic value of filing appeals for examiner FARRAR, LAUREN PENG.
With a 50.0% reversal rate, the PTAB reverses the examiner's rejections in a meaningful percentage of cases. This reversal rate is in the top 25% across the USPTO, indicating that appeals are more successful here than in most other areas.
Filing a Notice of Appeal can sometimes lead to allowance even before the appeal is fully briefed or decided by the PTAB. This occurs when the examiner or their supervisor reconsiders the rejection during the mandatory appeal conference (MPEP § 1207.01) after the appeal is filed.
In this dataset, 32.3% of applications that filed an appeal were subsequently allowed. This appeal filing benefit rate is below the USPTO average, suggesting that filing an appeal has limited effectiveness in prompting favorable reconsideration.
✓ Appeals to PTAB show good success rates. If you have a strong case on the merits, consider fully prosecuting the appeal to a Board decision.
⚠ Filing a Notice of Appeal shows limited benefit. Consider other strategies like interviews or amendments before appealing.
Examiner FARRAR, LAUREN PENG works in Art Unit 3783 and has examined 405 patent applications in our dataset. With an allowance rate of 82.5%, this examiner has an above-average tendency to allow applications. Applications typically reach final disposition in approximately 35 months.
Examiner FARRAR, LAUREN PENG's allowance rate of 82.5% places them in the 55% percentile among all USPTO examiners. This examiner has an above-average tendency to allow applications.
On average, applications examined by FARRAR, LAUREN PENG receive 2.44 office actions before reaching final disposition. This places the examiner in the 70% percentile for office actions issued. This examiner issues a slightly above-average number of office actions.
The median time to disposition (half-life) for applications examined by FARRAR, LAUREN PENG is 35 months. This places the examiner in the 41% percentile for prosecution speed. Prosecution timelines are slightly slower than average with this examiner.
Conducting an examiner interview provides a +9.9% benefit to allowance rate for applications examined by FARRAR, LAUREN PENG. This interview benefit is in the 43% percentile among all examiners. Recommendation: Interviews provide a below-average benefit with this examiner.
When applicants file an RCE with this examiner, 26.3% of applications are subsequently allowed. This success rate is in the 43% percentile among all examiners. Strategic Insight: RCEs show below-average effectiveness with this examiner. Carefully evaluate whether an RCE or continuation is the better strategy.
This examiner enters after-final amendments leading to allowance in 35.6% of cases where such amendments are filed. This entry rate is in the 53% percentile among all examiners. Strategic Recommendation: This examiner shows above-average receptiveness to after-final amendments. If your amendments clearly overcome the rejections and do not raise new issues, consider filing after-final amendments before resorting to an RCE.
When applicants request a pre-appeal conference (PAC) with this examiner, 57.1% result in withdrawal of the rejection or reopening of prosecution. This success rate is in the 49% percentile among all examiners. Note: Pre-appeal conferences show below-average success with this examiner. Consider whether your arguments are strong enough to warrant a PAC request.
This examiner withdraws rejections or reopens prosecution in 68.4% of appeals filed. This is in the 54% percentile among all examiners. Of these withdrawals, 38.5% occur early in the appeal process (after Notice of Appeal but before Appeal Brief). Strategic Insight: This examiner shows above-average willingness to reconsider rejections during appeals. The mandatory appeal conference (MPEP § 1207.01) provides an opportunity for reconsideration.
When applicants file petitions regarding this examiner's actions, 51.4% are granted (fully or in part). This grant rate is in the 51% percentile among all examiners. Strategic Note: Petitions show above-average success regarding this examiner's actions. Petitionable matters include restriction requirements (MPEP § 1002.02(c)(2)) and various procedural issues.
Examiner's Amendments: This examiner makes examiner's amendments in 0.0% of allowed cases (in the 46% percentile). This examiner makes examiner's amendments less often than average. You may need to make most claim amendments yourself.
Quayle Actions: This examiner issues Ex Parte Quayle actions in 0.0% of allowed cases (in the 49% percentile). This examiner issues Quayle actions less often than average. Allowances may come directly without a separate action for formal matters.
Based on the statistical analysis of this examiner's prosecution patterns, here are tailored strategic recommendations:
Not Legal Advice: The information provided in this report is for informational purposes only and does not constitute legal advice. You should consult with a qualified patent attorney or agent for advice specific to your situation.
No Guarantees: We do not provide any guarantees as to the accuracy, completeness, or timeliness of the statistics presented above. Patent prosecution statistics are derived from publicly available USPTO data and are subject to data quality limitations, processing errors, and changes in USPTO practices over time.
Limitation of Liability: Under no circumstances will IronCrow AI be liable for any outcome, decision, or action resulting from your reliance on the statistics, analysis, or recommendations presented in this report. Past prosecution patterns do not guarantee future results.
Use at Your Own Risk: While we strive to provide accurate and useful prosecution statistics, you should independently verify any information that is material to your prosecution strategy and use your professional judgment in all patent prosecution matters.